India Pesticides Limited reported a 34.8% year-on-year decline in standalone net profit after tax (PAT) to ₹23.07 crore for the quarter ended June 30, 2026, reflecting persistent headwinds in the domestic agrochemical sector. Consolidated PAT fell 34.8% to ₹22.77 crore. The decline was driven by an 8.6% drop in standalone revenue from operations to ₹252.56 crore from ₹275.41 crore in the corresponding period of FY26, attributed to softer domestic demand for its flagship herbicide, Pretilachlor, and increased operational costs including job work processing charges and fuel expenses.

The unaudited financial results were reviewed by the Audit Committee and approved by the Board of Directors at their meeting held on August 1, 2026. The results were subsequently reviewed by Statutory Auditors and filed with the stock exchanges pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company also published extracts of the results in Financial Express (English) and Jansatta (Hindi) on August 2, 2026.

Financial Performance Overview

Consolidated total income from operations stood at ₹251.76 crore, down from ₹275.18 crore in Q1FY26. The consolidated profit before tax was ₹30.85 crore, compared to ₹47.08 crore in the previous year. Earnings per share (basic and diluted) remained consistent at ₹1.98 for both standalone and consolidated figures.

Operational Pressures and Strategic Outlook

The divergence between gross profit stability and bottom-line contraction highlights rising operating leverage pressures. While gross margins have been maintained at healthy levels, downstream manufacturing costs, particularly job work processing charges which jumped to ₹14 crore from ₹8 crore year-on-year, eroded profitability. Export sales showed resilience, increasing marginally to ₹89 crore from ₹87 crore in Q1FY26, supported by stable international demand across 35+ countries, but this growth was insufficient to offset the domestic slowdown.

Dr. Kuruba Adeppa, Whole Time Director, noted that elevated channel inventory and higher fuel costs further strained profitability in the quarter. Despite near-term pressures, management emphasized a focus on operational efficiency and cost management. A key strategic milestone highlighted was the receipt of Technical Equivalence (TEQ) approval from the European Union for a fungicide product, strengthening the company’s position in international markets.

Capacity Expansion and Market Position

India Pesticides Limited continues to leverage its manufacturing capabilities across two primary facilities in Sandila, Hardoi, and Dewa Road, Lucknow, with a combined permitted capacity of 28,200 MT for technicals and 10,000 MT for formulations. A new facility in Hamirpur is under development; two out of ten operating blocks are currently functional for insecticides and herbicides. Two additional blocks are expected to become operational in FY27, contributing to a total permitted capacity expansion of 30,000 MT for technicals and 6,000 MT for formulations.

Revenue concentration remains a focus area, with top 10 customers accounting for 51% of revenue in Q1FY27, up from 40% in FY26. The company is actively reducing dependency on imported intermediates, particularly from China, through in-house R&D and project engineering capabilities, aiming to improve cost efficiencies while sustaining HSE and ESG standards.

India Pesticides Limited reported a significant decline in profitability for the first quarter of FY26, with standalone net profit falling 35% year-on-year to ₹23.07 crore. The drop was primarily driven by an increase in cost of materials consumed and higher other expenses, which offset benefits from inventory adjustments. This performance signals margin pressure in the agrochemicals segment as input costs remain elevated.

The Board of Directors approved the unaudited standalone and consolidated financial results on August 1, 2026, pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The results were reviewed by Suresh Surana & Associates LLP, the company's statutory auditors, under Regulation 33. The audit report noted that figures for the corresponding quarter ended June 30, 2025, were based on previously issued results reviewed by the predecessor auditor.

Financial Performance Highlights

Standalone revenue from operations decreased 8% to ₹252.56 crore from ₹275.41 crore in Q1FY25. Other income also saw a sharp decline, dropping 56% to ₹3.94 crore from ₹8.86 crore, largely due to the absence of a one-time insurance claim settlement received in the prior year. Total expenses rose 1% to ₹225.11 crore despite inventory write-downs reducing costs.

On a consolidated basis, revenue fell 8% to ₹251.76 crore, while net profit attributable to owners of the parent declined 34% to ₹22.74 crore. Earnings per share (basic) dropped to ₹1.98 from ₹3.03 in the previous year. The group includes subsidiaries Shalvis Specialities Limited and Amona Specialities Private Limited, whose interim results were reviewed by other auditors.

What the Numbers Show

The divergence between revenue decline and expense growth highlights structural cost pressures. While revenue fell 8%, the cost of materials consumed rose 9% to ₹184.11 crore, indicating that input inflation is not being fully passed on to customers or absorbed through efficiency gains. Although changes in inventories provided a benefit of ₹54.07 crore against a ₹11.78 crore benefit in the prior year, this operational advantage was insufficient to counterbalance the rise in other expenses, which jumped 19% to ₹69.28 crore. The compression in profit before tax from ₹47.62 crore to ₹31.39 crore underscores the vulnerability of margins to raw material volatility.

Regulatory and Tax Developments

The company disclosed ongoing proceedings with the Income Tax Department following a search conducted in December 2024. The Assessing Officer added ₹10.12 crore to undisclosed income, comprising ₹7.47 crore under Section 69 and ₹2.65 crore on account of profit embedded in unaccounted sales for FY2024-25. This resulted in an additional tax demand of ₹7.10 crore, net of ₹0.18 crore already paid. India Pesticides Limited has filed an appeal before the Joint Commissioner (Appeals)/Commissioner of Income-tax (Appeals), Lucknow, on July 24, 2026, maintaining that the demand is not tenable in law. The financial impact of these proceedings remains unascertainable pending finalization.